Search research articles
Contact Us
Filters
Showing results (71-80 of 173) with videos related to
Page
of 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group
K Behringer, A Josting, P Schiller, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
October 23, 2002
Photodynamic therapy mediated induction of accelerated re-endothelialisation following injury to the arterial wall: implications for the prevention of postinterventional restenosis
F Adili, T Scholz, M Hille, et al.
Cancer Research
|
May 15, 1990
Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice
A Engert, G Martin, M Pfreundschuh, et al.
Journal of Immunological Methods
|
July 12, 1994
Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation
H Bohlen, O Manzke, A Engert, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 6, 2016
Checkpoint inhibitors and radiation treatment in Hodgkin's lymphoma : New study concepts of the German Hodgkin Study Group
C Baues, R Semrau, U S Gaipl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1996
Interleukin 10 inhibits cytokine production of human AML cells
F Westermann, D Kube, B Haier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma
R Schnell, P Borchmann, J O Staak, et al.
Annals of Hematology
|
March 24, 1999
Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia
K Hübel, K Hegener, R Schnell, et al.
Blood
|
June 14, 2000
Ki-4(scFv)-ETA', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice
S Barth, M Huhn, B Matthey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2001
Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis
U Rueffer, A Josting, J Franklin, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 173) with videos related to
Sort By:
Page
of 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group
K Behringer, A Josting, P Schiller, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
October 23, 2002
Photodynamic therapy mediated induction of accelerated re-endothelialisation following injury to the arterial wall: implications for the prevention of postinterventional restenosis
F Adili, T Scholz, M Hille, et al.
Cancer Research
|
May 15, 1990
Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice
A Engert, G Martin, M Pfreundschuh, et al.
Journal of Immunological Methods
|
July 12, 1994
Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation
H Bohlen, O Manzke, A Engert, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 6, 2016
Checkpoint inhibitors and radiation treatment in Hodgkin's lymphoma : New study concepts of the German Hodgkin Study Group
C Baues, R Semrau, U S Gaipl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1996
Interleukin 10 inhibits cytokine production of human AML cells
F Westermann, D Kube, B Haier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma
R Schnell, P Borchmann, J O Staak, et al.
Annals of Hematology
|
March 24, 1999
Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia
K Hübel, K Hegener, R Schnell, et al.
Blood
|
June 14, 2000
Ki-4(scFv)-ETA', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice
S Barth, M Huhn, B Matthey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2001
Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis
U Rueffer, A Josting, J Franklin, et al.
Page
of 18